Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Proof of Concept Single-Center Study of the Use of Oritavancin in Systemic Staphylococcus Aureus Infections in Patients With Opioid Use Disorder

NCT03761953 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03761953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Proof of Concept Single-Center Study of the Use of Oritavancin in Systemic Staphylococcus Aureus Infections in Patients With Opioid Use Disorder
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Withdrawn
Start date
July 1, 2019
Completion date
March 24, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia, staphylococcus aureus endocarditis